Electroretinogram as a Screening Tool to Assess Vigabatrin-Induced Retinal Toxicity in Children With Infantile Spasms

Insights

Electroretinogram (ERG) effectively screens for vigabatrin-induced retinal toxicity in children with infantile spasms. Toxicity is linked to treatment duration, not cumulative dosage, highlighting the importance of regular ERG monitoring.

Area of Science:

  • Ophthalmology
  • Pediatric Neurology
  • Clinical Electrophysiology

Background:

  • Infantile spasms require vigabatrin treatment, which carries a risk of retinal toxicity.
  • Early detection of vigabatrin-induced retinal toxicity is crucial for preserving vision in children.

Purpose of the Study:

  • To evaluate the electroretinogram (ERG) as a screening tool for vigabatrin-induced retinal toxicity.
  • To assess the utility of ERG in monitoring pediatric patients with infantile spasms undergoing vigabatrin therapy.

Main Methods:

  • An observational cohort study involving children with infantile spasms treated with vigabatrin.
  • 30-Hz flicker potential ERG using the RETeval system was performed at baseline, 6 months, and 1 year.
  • Amplitude measurements were recorded to assess retinal function.

Main Results:

  • Eleven children were included; tuberous sclerosis was the most common cause of infantile spasms.
  • Significant ERG amplitude differences were observed at 6 and 12 months (P < .001).
  • 72.7% of children (8/11) exhibited vigabatrin-induced retinal toxicity, with toxicity correlated to treatment duration exceeding 6 months.

Conclusions:

  • Electroretinogram (ERG) is a valuable tool for monitoring vigabatrin-induced retinal toxicity in children with infantile spasms.
  • Vigabatrin-induced retinal toxicity appears to be associated with the duration of treatment rather than the total cumulative dose.
Abstract

Related Concept Videos